Nasal Congestion News and Research

RSS

A better understanding of SARS-CoV-2 in children

Researchers at Duke University School of Medicine in Durham, North Carolina, have conducted a study showing that Hispanic ethnicity is associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among children.

24 Aug 2020

One college’s pop-up COVID test: Stop and ‘smell the roses’ (or the coffee)

If all goes according to plan, Penn State University students who opt for an on-campus experience this fall will start in-person classes on Aug. 24 under the banner of a "Mask Up or Pack Up" campaign.

24 Aug 2020

Honey a better cough remedy than over-the-counter-medicines

Cough has many remedies, but one of the most popular ones is honey, which has been used for centuries. Now, new research claims honey may be a better treatment for cough and colds than over-the-counter medicines.

20 Aug 2020

Persistent hiccups an unusual COVID-19 symptom

Now, a team of researchers revealed another atypical symptom reported by patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19) – persistent hiccups.

10 Aug 2020

Researchers win grant to study why COVID-19 patients lose their sense of smell

Researchers at the University of Colorado Anschutz Medical Campus have won a grant to study why many infected with Covid-19 lose their sense of smell.

22 Jul 2020

ICUs become a ‘delirium factory’ for COVID patients

Doctors are fighting not only to save lives from COVID-19, but also to protect patients' brains.

3 Jun 2020

Challenges of diagnosing Lyme disease in the absence of classic symptoms

Lyme disease can have unusual presentations. Physicians and the public should be aware of its different manifestations, as people spend more time outside in the warmer weather and as the areas in Canada where the black legged tick is found expand.

26 May 2020

UTHealth experts successfully treat 3-week-old infant with severe COVID-19

In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/

28 Apr 2020

Study provides new insight into cluster headache chronicity

A prospective study recently published in the journal Cephalalgia, the official journal of the International Headache Society, extends the idea behind cluster headache chronicity.

2 Jan 2020

Clinical trial data demonstrates safety and efficacy of nasal congestion treatment device

Healthy Humming, LLC is pleased to announce positive topline data from a prospective outcomes study, which assessed the safety and efficacy of the SinuSonic, a nasal congestion treatment device that combines nasal acoustic vibration with oscillating expiratory pressure.

3 Dec 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019

I’m a CPAP dropout: Why many lose sleep over apnea treatment

When doctors told Frances Faulkenburg she had sleep apnea, she was more than ready for relief from her tired-all-the-time existence. She used to fall asleep at red lights while behind the wheel. At night, she'd wake up gasping for air, heart pounding. Her husband told her she snored.

17 Jul 2019

First treatment approved by FDA for chronic rhinosinusitis with nasal polyps

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).

26 Jun 2019

Study: Measles outbreaks may become more frequent if vaccination rates continue to decline

In 2000, measles was declared to be eliminated in the United States, when no sustained transmission of the virus was seen in this country for more than 12 months.

19 Apr 2019

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonists to improve immune cell trafficking to treat cancer and rare disease, today announced results from a pilot study of X4P-001-IO in combination with Opdivo (nivolumab) in patients with clear cell renal cell carcinoma who are non-responsive to the anti-PD-1 checkpoint inhibitor Opdivo alone.

22 Oct 2018

Aspirin desensitization can help alleviate alcohol-induced allergies in patients with AERD

Patients who suffer from Aspirin Exacerbated Respiratory Disease often experience an additional allergic reaction when drinking alcohol, including nasal congestion, wheezing, and a runny nose.

10 Jul 2018

Doctors use new non-invasive approach to treat nasal obstruction

Researchers at The Ohio State University Wexner Medical Center are exploring how small changes in the nasal cavity impact airflow and quality of life.

14 May 2018

Seasonal allergy symptoms can be misunderstood for learning disabilities in young children

Seasonal allergies can be a nuisance for children as well as adults. And in some young children, the symptoms of seasonal allergies can be mistaken for inattentiveness or learning disabilities.

7 May 2018

Study uncovers special receptor that protects against asthma, allergies

A special receptor on cells that line the sinuses, throat and lungs evolved to protect mammals from developing a range of allergies and asthma, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

27 Feb 2018

Infantile spasms and multiple sclerosis relapse data presented at AAN

Mallinckrodt plc, a specialty pharmaceutical company, announced new results from two company-sponsored studies: one study on use of H.P. Acthar® Gel (repository corticotropin injection) in patients with infantile spasms (IS) and a second study on the economic burden of moderate-to-severe multiple sclerosis (MS) relapse.

2 May 2017